Clonal Hematopoiesis in Patients Receiving Immune Checkpoint Inhibitor Therapy

被引：0
|
作者：
Singh, Abhay
Mencia-Trinchant, Nuria
Griffiths, Elizabeth A.
Gravina, Matthew
Tajammal, Rutaba
Faber, Mark G.
Nowak, Annmarie
Ernstoff, Marc S.
Yan, LunBiao
Herr, Megan M.
Hassane, Duane C.
Guzman, Monica L.
Wang, Eunice S.
Przespolewski, Amanda
Thota, Swapna
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141617
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
    Suresh, Karthik
    Psoter, Kevin J.
    Voong, Khinh Ranh
    Shankar, Bairavi
    Forde, Patrick M.
    Ettinger, David S.
    Marrone, Kristen A.
    Kelly, Ronan J.
    Hann, Christine L.
    Levy, Benjamin
    Feliciano, Josephine L.
    Brahmer, Julie R.
    Feller-Kopman, David
    Lerner, Andrew D.
    Lee, Hans
    Yarmus, Lonny
    Hales, Russell K.
    D'Alessio, Franco
    Danoff, Sonye K.
    Naidoo, Jarushka
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 494 - 502
  • [22] Cachectic Cancer Patients: Immune to Checkpoint Inhibitor Therapy?
    Coss, Christopher C.
    Clinton, Steven K.
    Phelps, Mitch A.
    CLINICAL CANCER RESEARCH, 2018, 24 (23) : 5787 - 5789
  • [23] Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease
    Johnson, Douglas B.
    Beckermann, Kathryn E.
    Wang, Daniel Y.
    ONCOLOGY-NEW YORK, 2018, 32 (04): : 190 - 194
  • [24] IMMUNE CHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH PREEXISTING SARCOIDOSIS
    Pundole, X.
    Lambotte, O.
    Ramos-Casals, M.
    Suarez-Almazor, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1221 - 1222
  • [25] AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
    Aude, C.
    Ghosh, N.
    Jannat-Khah, D.
    Chan, K. K.
    Postow, M.
    Larman, H.
    Bass, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1188 - 1189
  • [26] Associations between Immune-related Adverse Events and Prognosis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
    Inoue, Yusuke
    Inui, Naoki
    INTERNAL MEDICINE, 2024,
  • [27] Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy
    von Itzstein, Mitchell S.
    Gonugunta, Amrit S.
    Sheffield, Thomas
    Homsi, Jade
    Dowell, Jonathan E.
    Koh, Andrew Y.
    Raj, Prithvi
    Fattah, Farjana
    Wang, Yiqing
    Basava, Vijay S.
    Khan, Shaheen
    Park, Jason Y.
    Popat, Vinita
    Saltarski, Jessica M.
    Gloria-McCutchen, Yvonne
    Hsiehchen, David
    Ostmeyer, Jared
    Xie, Yang
    Li, Quan-Zhen
    Wakeland, Edward K.
    Gerber, David E.
    CANCERS, 2022, 14 (05)
  • [28] Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma
    Pennington, Thomas E.
    Zhao, Cathy Yunjia
    Colebatch, Andrew J.
    Fernandez-Penas, Pablo
    Guitera, Pascale
    Burke, Hazel
    Scolyer, Richard A.
    Menzies, Alexander M.
    Carlino, Matteo S.
    Lo, Serigne
    Long, Georgina, V
    Saw, Robyn P. M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (02) : E133 - E137
  • [29] Onset and Disease Course of Inflammatory Arthritis in Patients Receiving Immune Checkpoint Inhibitor Therapy at a Single Institution
    Boutsicaris, Christina
    Ciliberti, Angelo
    Lockerman, Elizabeth
    Siddique, Faizah
    Ostrowski, Rochella
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [30] Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapy
    Zhang, Lilong
    Chen, Chen
    Chai, Dongqi
    Li, Chunlei
    Kuang, Tianrui
    Liu, Li
    Dong, Keshuai
    Deng, Wenhong
    Wang, Weixing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345